|
Central Africa International Epidemiologic Database to Evaluate AIDS
|
5U01AI096299-09
|
$260,000
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-04
|
$701,778
|
$14,036
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
5U01CA078527-21
|
$581,591
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of macroH2A variants in cancer and senescence
|
5R01CA155232-08
|
$382,013
|
|
GAMBLE, MATTHEW
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Epigenetic activity of normal and cancer-associated mutant H1 linker histones
|
5F30CA210539-03
|
$44,524
|
|
HEALTON, SEAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm
|
5R01CA077263-19
|
$417,500
|
|
MCDAID, HAYLEY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Optimization of Non-Ablative Focused Ultrasound Therapy for Tumor Immunity
|
5F30CA200411-05
|
$49,524
|
|
SKALINA, KARIN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Contributions of sympathetic signals to prostate cancer progression.
|
5F30CA203446-03
|
$49,524
|
|
ZAHALKA, ALI
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Methods in Clinical Cancer Research Workshop
|
5R25CA068647-21
|
$224,999
|
|
VON HOFF, DANIEL
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Stand and Move at Work: A Group-Randomized Trial
|
5R01CA198971-04
|
$582,484
|
|
BUMAN, MATTHEW
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Multiplexed In Solution Protein Array (MISPA) for identifying novel protein interactions in cancer and for early detection of immune responses in pathogen-induced cancers
|
5R21CA196442-03
|
$201,623
|
$201,623
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Investigation of Biomarkers for Sugars Intake - A Controlled Feeding Study
|
5U01CA197902-04
|
$571,401
|
|
TASEVSKA, NATASHA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Role of SLC13A3 in Renal Cell Carcinoma
|
5F31CA210612-03
|
$29,664
|
|
JORDAN, ANDRE
|
AUGUSTA UNIVERSITY
|
|
Role of IRF8 in Tumor Rejection and Suppression
|
5R01CA133085-09
|
$307,800
|
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression
|
5R01CA182518-05
|
$315,400
|
|
LIU, KEBIN
|
AUGUSTA UNIVERSITY
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Sox9/NFIA Transcriptional Network In Malignant Glioma
|
5K01CA190235-04
|
$140,400
|
|
GLASGOW, STACEY
|
BAYLOR COLLEGE OF MEDICINE
|
|
ENHANCING T CELL THERAPY OF CANCER
|
5P01CA094237-15
|
$1,932,287
|
$463,749
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$2,367
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$2,445
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$5,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$65,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers
|
1R01CA216426-01A1
|
$427,819
|
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Hormonal Regulation of Breast Cancer
|
2R01CA016303-42A1
|
$480,181
|
|
ROSEN, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
|
New Vulnerabilities in MYC-Driven Breast Cancer
|
1R01CA215226-01A1
|
$598,309
|
|
WESTBROOK, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer
|
5R01CA184792-04
|
$347,517
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-04
|
$604,525
|
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
5R01CA197359-04
|
$388,875
|
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures
|
5U01ES026137-04
|
$250,000
|
|
CHEN, SHIUAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
|
1R01CA215183-01A1
|
$529,603
|
|
KORTYLEWSKI, MARCIN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Epigenetic damage in women living in LA food-desert zip codes
|
5R01CA220693-02
|
$700,834
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
DNA Damage Response and Oncogenic Signaling
|
5T32CA186895-03
|
$181,497
|
|
SHEN, BINGHUI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5R01CA166894-06
|
$368,984
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unmet needs for specific subsets of EGFR mutated lung cancer
|
1R37CA218707-01A1
|
$409,171
|
|
COSTA, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
FANCM in repair of stalled replication forks
|
5R01CA217991-02
|
$395,738
|
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization
|
5R01CA200651-02
|
$383,385
|
$383,385
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell carcinoma
|
1R43CA224512-01
|
$299,340
|
$299,340
|
BERTENSHAW, GREG
|
BIOMARKER STRATEGIES, LLC
|
|
c-Met-induced Renalase: a novel therapeutic target for renal cancer
|
1R03CA219731-01A1
|
$88,500
|
|
BALAN, MURUGABASKAR
|
BOSTON CHILDREN'S HOSPITAL
|
|
Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma
|
5R01CA196703-04
|
$404,888
|
|
CHIARLE, ROBERTO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Structural mechanisms underlying latency and activation of GDF8
|
5R01CA210920-03
|
$394,594
|
|
SPRINGER, TIMOTHY
|
BOSTON CHILDREN'S HOSPITAL
|
|
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future
|
1R01CA227576-01
|
$460,299
|
|
YEH, JENNIFER
|
BOSTON CHILDREN'S HOSPITAL
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
5R01CA201446-03
|
$377,438
|
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
An interactive analysis toolkit for single cell RNA-seq in cancer research
|
5U01CA220413-02
|
$385,402
|
|
JOHNSON, WILLIAM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-03
|
$590,572
|
$590,572
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
3U24CA180918-05S1
|
$254,713
|
$84,055
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
5U24CA180918-05
|
$668,865
|
$220,725
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developing miR-10b targeting for glioblastoma
|
1R01CA215072-01A1
|
$408,884
|
|
KRICHEVSKY, ANNA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Fate and efficacy of targeted therapies for metastatic tumors
|
5R01CA201148-04
|
$388,180
|
|
SHAH, KHALID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Head and Neck for this search: $68,087,550
|